Thursday, September 10, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Cautious Normal choppiness · VIX 17.3
The FTSE 100 is in a broad, sharp risk-off drawdown: the vast majority of constituents are down 5-20% over the past 30 days and sit well off their 52-week highs, consistent with an index-wide de-rating rather than isolated stock news. A narrow set of names -- energy majors, a handful of insurers/testing firms near their highs, and EM-tilted financials -- are bucking the trend, but genuine 30-day upside candidates are scarce.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
Nothing new to buy today — hold the positions you already have.
Already open: DXCM (to Sep 11), BDX (to Sep 12), EXPD (to Sep 13), CPAY (to Sep 16), GPN (to Sep 16), STT (to Sep 16), STJ.L (to Sep 16), SCHW (to Sep 17), TRGP (to Sep 17), AV.L (to Sep 17), PSN.L (to Sep 17), CVX (to Sep 18) … and 97 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
All five agents analyzed the candidates but did not find any stocks meeting the probability threshold for this target.
No stock cleared the bar this run. Below is what each analyst selected and why it did not make the final report, plus the candidates each one passed over.
Candidates passed over
Stocks this agent selected
Candidates passed over
Candidates passed over
Candidates passed over
Scout scanned 100 FTSE 100 constituents and short-listed 15 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.